European Neuropsychopharmacology
Volume 13, Issue 5 , Pages 337-345 , October 2003

Effects of serotonin 5-HT1/2 receptor agonists in a limited-access operant food intake paradigm in the rat

Received 5 November 2002 ,Accepted 7 January 2003.

References 

  1. Aulakh CS, Hill JL, Yoney HT, Murphy DL. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Psychopharmacology. 1992;109:444–448
  2. Aulakh CS, Mazzola-Pomietto P, Hulihan-Giblin BA, Murphy DL. Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively. Neuropsychopharmacology. 1995;13:1–8
  3. Blundell JE. Is there a role for serotonin (5-hydroxytryptamine) in feeding?. Int. J. Obesity. 1977;1:15–42
  4. Blundell JE. Serotonin and appetite. Neuropharmacology. 1984;23:1537–1551
  5. Blundell JE, Halford JCG. Serotonin and appetite regulation: implications for the pharmacological treatment of obesity. CNS Drugs. 1998;9:473–495
  6. Bovetto S, Richard D. Functional assessment of the 5-HT 1A-, 1B, 2A/2C- and 3-receptor subtypes on food intake and metabolic rate in rats. Am. J. Physiol. 1995;268:R14–R20
  7. Clifton PG, Barnfield AM, Curzon G. Effects of food deprivation and mCPP treatment on the microstructure of ingestive behaviour of male and female rats. J. Psychopharmacol. 1993;7:257–264
  8. Clifton PG, Lee MD, Dourish CT. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat. Psychopharmacology. 2000;152:256–267
  9. Curzon G. Effects of tryptophan and 5-hydroxytryptamine receptor subtype agonists on feeding. Adv. Exp. Med. Biol. 1991;294:377–388
  10. De Beun R, Lohmann A, Schneider R, De Vry J. Ethanol intake-reducing effects of ipsapirone in rats are not due to simple stimulus substitution. Pharmacol. Biochem. Behav. 1996;53:891–898
  11. De Vry J. 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology. 1995;121:1–26
  12. De Vry J, Schreiber R. Effects of selected 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action. Neurosci. Biobehav. Rev. 2000;24:341–353
  13. De Vry J, Eckel G, Kuhl E, Schreiber R. Effects of selective 5-HT1/2 receptor agonists in a conditioned taste aversion paradigm in rats. Pharmacol. Biochem. Behav. 2000;66:797–802
  14. De Vry J, Glaser T, Schuurman T, Schreiber R, Traber J. 5-HT1A receptors in anxiety. In:  Briley M,  File SE editor. New Concepts in Anxiety. London: MacMillan Press; 1991;p. 94–129
  15. Dourish CT. Multiple serotonin receptors: opportunities for new treatments for obesity?. Obesity Res. 1995;3:449S–462S
  16. Ebenezer IS. Effects of the 5-HT1A agonist 8-OH-DPAT on food intake in food-deprived rats. Neuroreport. 1992;3:1019–1022
  17. Ebenezer IS, Tite R. The dose-related effects of the 5-HT1A agonist gepirone on operant and non-operant food intake in food-deprived rats. Br. J. Pharmacol. 1995;116:227P
  18. Fletcher PJ, Davies M. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone. Br. J. Pharmacol. 1990;99:519–525
  19. Fuller RW, Snoddy HD, Mason NR, Owen JE. Disposition and pharmacological effects of m-chlorophenylpiperazine in rats. Neuropharmacology. 1981;20:155–162
  20. Fuller RW, Snoddy HD, Mason NR, Hemrick-Luecke SK, Clemens JA. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine. J. Pharmacol. Exp. Ther. 1981;218:636–641
  21. Gilbert F, Dourish CT. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and feeding induced by 8-OH-DPAT. Psychopharmacology. 1987;93:349–352
  22. Grill HJ, Song S, Kaplan JM. Caudal brainstem 5-HT1B receptors contribute to the anorectic effects of CP94-253 and CP93-129. Soc. Neurosci. Abstr. 1997;23:514
  23. Grottick AJ, Corrigall WA, Higgins GA. Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology. 2001;157:292–298
  24. Grottick AJ, Fletcher PJ, Higgins GA. Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior. J. Pharmacol. Exp. Ther. 2000;295:1183–1191
  25. Halford JCG, Blundell JE. The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence. Physiol. Behav. 1996;60:933–939
  26. Halford JCG, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann. Med. 2000;32:222–232
  27. Halford JCG, Wanninayake SCD, Blundell JE. Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol. Biochem. Behav. 1998;61:159–168
  28. Kaplan JM, Song S, Grill HJ. Serotonin receptors in the caudal brainstem are necessary and sufficient for the anorectic effect of peripherally administered mCPP. Psychopharmacology. 1998;137:43–49
  29. Kennett GA, Ainsworth K, Trail B, Blackburn TP. BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology. 1997;36:233–239
  30. Kitchener SJ, Dourish CT. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology. 1994;113:369–377
  31. Koe BK, Nielsen JA, Macor JE, Heym J. Biochemical and behavioural studies of the 5-HT1B receptor agonist, CP-94,253. Drug Dev. Res. 1992;26:241–250
  32. Lee MD, Simansky KJ. CP-94,253: a selective serotonin1B (5-HT1B) agonist that promotes satiety. Psychopharmacology. 1997;131:264–270
  33. Leysen D, Kelder J. Ligands for the 5-HT2C receptor as potential antidepressants and anxiolytics. In:  van der Groot H editors. Trends in Drug Research. Amsterdam: Elsevier; 1998;p. 49–61
  34. Mancilla-Dı́az JM, Escartı́n-Pérez RE, López-Alonso VE, Cruz-Morales SE. Effect of 5-HT in mianserin-pretreated rats on the structure of feeding behavior. Eur. Neuropsychopharmacol. 2002;12:445–451
  35. Samanin R, Grignaschi S. Role of 5-hydroxytryptamine receptor subtypes in satiety and animal models of eating disorders. In:  Cooper SJ,  Clifton PG editor. Drug Receptor Subtypes and Ingestive Behaviour. London: Academic Press; 1996;p. 39–58
  36. Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S. m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn Schmiedeberg’s Arch. Pharmacol. 1979;308:159–163
  37. Schechter LE, Simansky KJ. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats. Psychopharmacology. 1988;94:342–346
  38. Schreiber R, De Vry J. Role of 5-HT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the rat. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2002;26:441–449
  39. Schreiber R, Selbach K, Asmussen M, Hesse D, De Vry J. Effects of serotonin1/2 receptor agonists on dark-phase food and water intake in rats. Pharmacol. Biochem. Behav. 2000;67:291–305
  40. Shannon M, Battaglia G, Glennon RA, Titeler M. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Eur. J. Pharmacol. 1984;102:23–29
  41. Simansky KJ. Serotonergic control of the organisation of feeding and satiety. Behav. Brain Res. 1996;73:37–42
  42. Simansky KJ, Vaidya AH. Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Brain Res. Bull. 1990;25:953–960
  43. Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidel P-R. Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res. Bull. 1984;12:741–744
  44. Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, et al. Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists. Pharmacol. Biochem. Behav. 2001;69:643–652
  45. Wolff MC, Leander JD. A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon. Behav. Pharmacol. 2000;11:355–364
  46. Wong DT, Reid LR. Fenfluramine antagonizes the stimulation of food intake induced by the putative 5-hydroxytryptamine1A agonist, isapirone, in non-fasted rats. J. Pharm. Pharmacol. 1987;39:570–571

PII: S0924-977X(03)00014-2

doi: 10.1016/S0924-977X(03)00014-2

European Neuropsychopharmacology
Volume 13, Issue 5 , Pages 337-345 , October 2003

Article Tools

* Image Usage & Resolution